PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.92%
Negative revenue growth while NXPI stands at 3.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-9.52%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
-17.63%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-17.63%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-4.84%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-2.13%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
No Data
No Data available this quarter, please select a different quarter.
-2.52%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.41%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
29.35%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
101.67%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
341.26%
FCF growth above 1.5x NXPI's 94.26%. David Dodd would verify if the firm’s strategic investments yield superior returns.
204.26%
10Y revenue/share CAGR above 1.5x NXPI's 79.10%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
111.21%
5Y revenue/share CAGR 1.25-1.5x NXPI's 77.31%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
120.70%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
37.20%
10Y OCF/share CAGR under 50% of NXPI's 104.58%. Michael Burry would worry about a persistent underperformance in cash creation.
18.07%
Below 50% of NXPI's 107.18%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
39.81%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
2571.27%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
727.64%
5Y net income/share CAGR above 1.5x NXPI's 328.95%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
129.87%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
187.22%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
4.23%
Below 50% of NXPI's 18.89%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
69.04%
3Y equity/share CAGR above 1.5x NXPI's 42.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
87.75%
Dividend/share CAGR of 87.75% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
75.60%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
184.42%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-15.08%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-3.62%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-5.78%
Negative asset growth while NXPI invests at 0.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.10%
We have a declining book value while NXPI shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-2.46%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.39%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.